Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled, Double-blind Study to Evaluate Safety and Dose Dependent Clinical Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer

NCT04277598 is registered in ClinicalTrials.gov with Aposcience AG as lead sponsor.

NCT NCT04277598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04277598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled, Double-blind Study to Evaluate Safety and Dose Dependent Clinical Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer
Lead sponsor
Aposcience AG
Phase
Phase 1/2
Overall status
Completed
Start date
October 9, 2020
Completion date
December 6, 2023
Enrollment
159 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer (dfu)